The goal of Additive Orthopaedics is the integration of advanced manufacturing and biologics for the benefit of a better patient outcome. The company is laser focused on leveraging the patient, technological and cost benefits of additive manufacturing into the global orthopaedics market. Additive Manufacturing allows us to develop advanced orthopaedic devices, with complex geometries, never before possible with older, and subtractive manufacturing processes.
Director of Marketing
Director of Engineering
Board of Directors
Alan M. Meckler, Ph.D.
Alan M. Meckler, Ph.D. was the first media professionals to spot the potential of the commercial Internet (1990). He launched INTERNET WORLD magazine and trade show in 1993. These properties were sold for $274 million cash in 1998. Meckler also created the trade show Search Engine Strategies in 2000 and sold the shows and companion website for $47 million in cash. He purchased Jupiter Research out of bankruptcy in 2002 and later sold it for a 5000 percent return. He was CEO overseeing three public offerings and two secondary offerings (1994-2013). Currently Meckler is CEO of 3DR Holdings based in New York City. The organization operates four 3D Printing trade shows (Boston, Delhi, Sao Paulo and Seoul); two Quantum Computing conferences (Delft and New York City); the websites 3DPrint.com and InsideQuantumTechnology.com; and investments in the 3D Printing research company SmarTechAnalysis.com. Meckler is also the general partner of the early-stage VC firm AsimovVentures.com (which invests in 3D Printing, Robotics, Blockchain and additional technology areas). Meckler has a Ph.D. in American history from Columbia University, has written several books and has been published in THE NEW YORKER. He served in the United States Army Reserve and New York Air National Guard (1969-1975).
Mike Schuler has been in the medical device industry for over 40 years. In addition to his work as the Founder and Partner of Tri-medics, Mr. Schuler is the VP of New Business Development at the Musculoskeletal Transplant Foundation at MTF where he has served since 2002. Prior to MTF, Mike was an independent planning and new business development with major assignments including Olympus, Vidar, PNavel, HET and others. he served as Imagyn Medical Technologies as President Surgical Division, where he successfully consolidated 3 divisions. Mr. Schuler spent his first professional 18 years with Johnson and Johnson, we progressively held positions of increasing responsibility. He leads the assessment of the Palmax-Schatz Stent, helping the company acquire the breakthrough technology, and later, as Head of Marketing, was responsible for the launch of the first intravascular stent. Mr. Schuler remains active with his Alma Mater, Rutgers University, where he serves on various Industry Advisory Committees.
Tony Dimun brings over 30 years of highly successful operational, business development, and financial experience in the healthcare marketplace. Since 2001, he has served as Chairman of Nascent Enterprises, LLC, a group of medical industry entrepreneurs focused on successful commercialization of promising medical device inventions. From 1987 to 2001, he served as Executive Vice president & Chief Financial Officer of Vital Signs, Inc., a publicly held anesthesia, respiratory and sleep apnea medical device business, providing growth strategies to enhance the Company’s value through highly focused bolt on acquisitions. Vital Signs was sold to GE Medical in 2008 for $900 million.
During the last 20 years he has been an investor and mentor to several emerging growth medical enterprises that have matured to commercial status and became publicly traded companies, acting either as the Founder or participating in the finding of 21 medical device companies. Of these enterprises, four became public companies and eight were sold. Mr. Dimun has been a director of several public companies, including, Vital Signs, Inc., Bionx Implants, Inc., Colorado MedTech Inc., Photomedix, ISS Surgical Systems and numerous privately held companies in the healthcare industry. He also served on the Board of Advisors of the Rutgers University Technology Center & the Biomaterial Institute of Rutgers University and through Nascent Enterprises provides the University of Pennsylvania with entrepreneurial assistance to commercialize Penn’s medical technology. Prior to 1991, Mr. Dimun held positions as a Certified Public Accountant with national accounting firms and served as Senior VP for an international merchant banking firm specializing in mergers & acquisitions.
GAME PLAN ® by Additive Orthopaedics
Powering our patient specific implants, Game Plan is an end-to-end fully integrated cloud based communication system that aligns surgeons and engineers to optimize patient outcomes.
How can we
Help You Today
To work with us...
Want to learn more about Additive Orthopaedics and what we can do for you?